HEPATITIS C: FREQUENCY AND RISK FACTORS ASSOCIATED WITH SERO-POSITIVITY AMONG ADULTS IN LARKANA CITY

Authors

  • Fida Hussain Shaikh
  • Hakim Ali Abro
  • Mumtaz Ali Chhutto
  • Parvez Ahmed Abbasi
  • Abdul Wahab Shaikh
  • Sheeraz Ali Buriro

Abstract

Background: Viral hepatitis is a major public health problem. Infection with Hepatitis C virus
(HCV) leads to chronicity and there are about 170 million people infected with HCV. Up to 70%
of chronically infected individuals develop active liver disease. The Objective of the study was to
find out the frequency of Anti-HCV seropositivity and risk factors of Hepatitis C Virus (HCV)
transmission in people of Larkana city. Method: The study was conducted at Larkana from April
2006 to April 2007. Camps were established in the main general practitioners' clinics. A
questionnaire about knowledge of HCV and risk factors of its transmission was administered to
subjects. Descriptive statistics were done by SPSS-10. Result: Total 450 cases were enrolled into
this study. They were divided into 3 age groups. Eighty-nine (19.8%) cases were in age group <20
years, 262 (58.2%) were in age group 20-40 years and 99 (22.0%) were in age group >40 years.
There were 353 (78.4%) male and 97 (21.6%) female subjects, out of these 450 cases 30 (6.6%)
were positive for Anti-HCV. A number of risk factors of HCV transmission were present in these
cases. History of therapeutic injections was present in 72 cases and 35 cases used public barber
services. Conclusion: History of therapeutic injections and use of barber services for shave were
the most frequent risk factors in our study.
Keywords: Risk factors, HCV, Sero-positivity, Hepatitis, Cirrhosis, Hepatocellular Carcinoma

References

Perlman BL. Hepatitis C infection: a clinical review. South Med

J 2004;97(4):364-73.

WHO. Global Surveillance and Control of hepatitis C: Report of

a WHO Consultation organized in collaboration with the Viral

Hepatitis Prevention Board, Antwerp. Belgium. J Viral Hepat

;6:35-47.

Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil

AO, Viladomiu L, et al. Routes of infection, viremia and liver

disease in blood donors found to have hepatitis C virus infection.

N Engl J Med 1996;334:1691-6.

Zein NN. The epidemiology and natural history of hepatitis C

virus infection. Cleve Clin J Med 2003;70 (Suppl 4):S2-6.

Umar M, Bushra HT, Shuaib A, Anwar A, Shah NH. Spectrum

of chronic liver disease due to hepatitis C virus infection. J Coll

Physicians Surg Pak 2000;10:380-3.

Haider Z, Khan AA, Rehman K, Janjua MI, Iqbal J, Chishti A, et

al. Sero-diagnosis for viral hepatitis in 93 patients admitted with

acute hepatitis in three different teaching hospitals in Lahore. J

Pak Med Assoc 1994;44:182-4.

Hamid S, Tabbasum S, Jafri W. Hepatitis C has replaced

Hepatitis B as the major cause of chronic liver disease in

Pakistan. Hepatology 1999;30:212A.

Chohan AR, Umar M, Khaar B, Khurram M, Zahid M, Shah SF,

et al. Demographic features of hepatocellular carcinoma. A study

of 30 cases. J Rawl Med Coll 2001;5(2):81-3.

Lubey S, Khanani R, Zia M, Vellani Z, Ali M, Qureshi H, et al.

Evaluation of blood bank practices in Karachi, Pakistan and the

government's response. Health Policy Plan 2000;15:217-22.

Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S, et

al. Unsafe injections and the transmission of hepatitis B and C in

a periurban community in Pakistan. Bull World Health Organ

;78:956-63.

Jafri W, Jafri N, Yakoob J, Islam M, Tirmizi SFA, Jafar T, et al.

Hepatitis B and C: prevalence and risk factors associated with

seropositivity among children in Karachi, Pakistan. BMC Infect

Dis 2006;6:101.

Bari A, Akhtar S, Rahbar MH, Luby SP. Risk factors for

hepatitis C virus infection in male adults in RawalpindiIslamabad, Pakistan. Trop Med Int Health 2001;6:732-8.

Sheikh SN, Tayyab N, Jaffery G, Tasneem T, Sattar A, Ali I. AntiHCV detection. A comparison between methodology: Elisa Vs

Dipstick Assay. J Ayub Med Coll Abbottabad 1999;11(1):30-3.

Qureshi M, Bengali K. The State of Education, In: Social

Development in Pakistan, Annual Review 2002-2003. Social

Policy and Development Centre Karachi, Times Press: iii-iv.

Hepatitis C: global prevalence. Wkly Epidemiol Rec

;72:341-4.

Roy KM, Goldberg D, Taylor A, Mills P. Investigating the

source of hepatitis C virus infection among individuals whose

route of infection is undefined: a study of ten cases. Scand J

Infect Dis 2003;35:326-8.

Luby SP, Qamruddin K, Shah AA, Omair A, Pasha O, Khan AJ,

et al. The relationship between therapeutic injections and high

prevalence of hepatitis C infection in Hafizabad, Pakistan.

Epidemiol Infect 1997;119:349-56.

Shaikh MA, Shaikh WM, Solangi GA, Abro H. Frequency and

transmission in mode of hepatitis C virus in northern Sindh. J

Coll Physicians Surg Pak 2003;13:691-3.

Ahmad K. Pakistan: a cirrhotic state? Lancet 2004;364:1843-4.

Khan AJ. Unsafe injections and the transmission of hepatitis B

and C in a Periurban community in Pakistan. Bull World Health

Organ 2000;78:956-63.

Published

2009-06-01

How to Cite

Shaikh, F. H., Abro, H. A., Chhutto, M. A., Abbasi, P. A., Shaikh, A. W., & Buriro, S. A. (2009). HEPATITIS C: FREQUENCY AND RISK FACTORS ASSOCIATED WITH SERO-POSITIVITY AMONG ADULTS IN LARKANA CITY. Journal of Ayub Medical College Abbottabad, 21(2), 107–109. Retrieved from https://jamc.ayubmed.edu.pk/index.php/jamc/article/view/3637